Biotechnological production and applications of statins

Applied Microbiology and Biotechnology

Volumn 85, Issue 4, 2010, Pages 869-883

  Barrios González, Javier ^a   Miranda, Roxana U ^a  

^a DEPARTAMENTO DE QUÍMICA   (Mexico)

Author keywords

Biosynthesis and genetics; Biotechnological production; Statins

Indexed keywords

BIOCHEMISTRY; BIOSYNTHESIS; BIOTECHNOLOGY; CHAINS; CHROMOSOMES; FERMENTATION; KETONES;

BIOTECHNOLOGICAL PRODUCTION; EMERGING TECHNOLOGIES; PENICILLIUM CITRINUM; POLYKETIDE SYNTHASES; SEMI-SYNTHETIC DERIVATIVES; SOLID-STATE FERMENTATION; STATINS; SUBMERGED FERMENTATION;

ASPERGILLUS;

ACYLTRANSFERASE; ATORVASTATIN; COMPACTIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; MEVINOLIN; MONACOLIN J; MONACOLIN L; PITAVASTATIN; POLYKETIDE SYNTHASE; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

BIOCHEMISTRY; BIOTECHNOLOGY; CARDIOVASCULAR DISEASE; DRUG; ENZYME ACTIVITY; FERMENTATION; FUNGUS; GENE EXPRESSION; HEALTH RISK; REACTION KINETICS;

ALZHEIMER DISEASE; ASPERGILLUS TERREUS; BIOREACTOR; BIOTECHNOLOGICAL PRODUCTION; BIOTRANSFORMATION; CARDIOVASCULAR RISK; CHEMICAL STRUCTURE; DIABETES MELLITUS; DRUG HYDROXYLATION; DRUG ISOLATION; DRUG MANUFACTURE; DRUG SYNTHESIS; FUNGAL STRAIN; FUNGUS ISOLATION; FUNGUS MUTANT; GENETIC ENGINEERING; HUMAN; HYBRID; HYPERCHOLESTEROLEMIA; IN VIVO STUDY; METABOLIC SYNDROME X; MONASCUS; MONASCUS RUBER; MULTIPLE SCLEROSIS; MYCELIUM; NEOPLASM; NONHUMAN; OSSIFICATION; OSTEOPOROSIS; PARKINSON DISEASE; PENICILLIUM CITRINUM; RHEUMATOID ARTHRITIS; RICE; SHORT SURVEY; SOLID STATE FERMENTATION; SOYBEAN; SUBMERGED FERMENTATION; SUGARCANE; WHEAT BRAN;

ASPERGILLUS TERREUS; PENICILLIUM CITRINUM;

EID: 76649090282     PISSN: 01757598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00253-009-2239-6     Document Type: Short Survey

References (109)

1. Y Abe T Suzuki C Ono K Iwamoto M Hosobuchi H Yoshikawa 2002 Molecular cloning and characterization of an ML-236B (compactin) biosynthetic gene cluster in Penicillium citrinum Mol Gen Genomics 267 636 646 10.1007/s00438-002-0697-y 1:CAS:528:DC%2BD38XntFaksL0%3D (Pubitemid 34824193)
2. RM Adibhatla JF Hatcher 2008 Altered lipid metabolism in brain injury and disorders Subcell Biochem 49 241 68 10.1007/978-1-4020-8831-5-9
3. AW Alberts J Chen G Kurov V Hunt J Huff C Hoffman J Rothrock M Lopez H Joshua E Harris A Patchett R Monaghan S Currie E Stapley G Albers-Schonberg O Hensens J Hirschfield KJ Hoofsteen J Liesch J Springer 1980 Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent Proc Natl Acad Sci USA 77 3957 3961 10.1073/pnas.77.7.3957 1:CAS:528:DyaL3cXlvFOlurk%3D (Pubitemid 10015499)
4. M Askenazi EM Driggers DA Holtzman TC Norman S Iverson DP Zimmer ME Boers PR Blomquist EJ Martinez AW Monreal TP Feibelman ME Mayorga ME Maxon K Sykes JV Tobin E Cordero SR Salama J Trueheart JC Royer KT Madden 2003 Integrating transcriptional and metabolite profiles to direct the engineering of lovastatin-producing fungal strains Nat Biotechnol 21 150 156 10.1038/nbt781 1:CAS:528:DC%2BD3sXnsFWiug%3D%3D (Pubitemid 36188213)
5. S Baba T Nihita M Hosobuchi 2008 Identification of the specific sequence recognized by MlcR, a GAL4-type transcriptional activator of ML-236B (compactin) biosynthetic genes Fungal Genet Biol 45 1277 1283 10.1016/j.fgb.2008.07.002 1:CAS:528:DC%2BD1cXhtVKmsb%2FN
6. S Baba Y Abe T Suzuki C Ono K Iwamoto T Nihira M Hosobuchi 2009 Improvement of compactin (ML-236B) production by genetic engineering in compactin high-producing Penicillium citrinum Appl Microbiol Biotechnol 83 697 704 10.1007/s00253-009-1933-8 1:CAS:528:DC%2BD1MXmslOksrg%3D
7. K Balakrishna A Pandey 1996 Production of biologically active secondary metabolites in solid state fermentation J Sci Ind Res 55 365 372 (Pubitemid 126582590)
8. JG Baños A Tomasini G Szakács J Barrios-González 2009 High lovastatin production by Aspergillus terreus in solid-state fermentation on polyurethane foam: an artificial inert support J Biosci Bioeng 108 105 110 10.1016/j.jbiosc.2009.03.006
9. J Barrios-González A Mejía 1996 Secondary metabolites production by solid state fermentation Biotechnol Annual Rev 2 85 121 10.1016/S1387-2656(08)70007-3
10. Barrios-González J, Mejía A, Larroche C (2007) Production of antibiotics and other commercially valuable secondary metabolites. In: Pandey A, Soccol C (eds) Current Developments in Solid-State Fermentation. Asiatech Publishers, Inc, New Delhi, pp 262-296
11. J Barrios-González FJ Fernández A Tomasini 2003 Production of microbial secondary metabolites and strain improvement J Biotechnol Special Issue: Microbial Biotechnology 2 322 333
12. J Barrios-González JG Baños AA Covarrubias A Garay-Arroyo 2008 Lovastatin biosynthetic genes of Aspergillus terreus are differentially expressed in solid-state and in liquid submerged fermentation Appl Microbiol Biotechnol 79 179 186 10.1007/s00253-008-1409-2
13. C Becker SS Jick CR Meier 2008 Use of statins and the risk of Parkinson's disease: a retrospective case-control study in the UK Drug Saf 31 399 407 10.2165/00002018-200831050-00004 1:CAS:528:DC%2BD1cXntVWgt7Y%3D (Pubitemid 351563732)
14. R Bigelis H He HY Yang LP Chang M Greenstein 2006 Production of fungal antibiotics using polymeric solid supports in solid-state and liquid fermentation J Ind Microbiol Biotechnol 33 815 826 10.1007/s10295-006-0126-z 1:CAS:528:DC%2BD28XptVWrs7k%3D (Pubitemid 44339454)
15. M Bizukojc S Ledakowicz 2008 Biosynthesis of lovastatin and (+)-geodin by Aspergillus terreus in batch and fed-batch culture in the stirred tank bioreactor Biochem Eng J 42 198 207 10.1016/j.bej.2008.06.022 1:CAS:528:DC%2BD1cXhtFektrrJ
16. M Bizukojc S Ledakowics 2009 Physiological, morphological and kinetic aspects of lovastatin biosynthesis by Aspergillus terreus Biotechnol J 4 647 664 10.1002/biot.200800289 1:CAS:528:DC%2BD1MXmvFChu7Y%3D
17. S Bonovas K Filioussi N Tsavaris NM Sitaras 2006 Statins and cancer risk: a literature-based meta-analysis and meta-regression analysis of 35 randomized controlled trials J Clin Oncol 24 4808 4817 10.1200/JCO.2006.06.3560 1:CAS:528:DC%2BD28Xht1eiu73M (Pubitemid 46655612)
18. Buckland B, Gbewonyo K, Hallada T, Kaplan L, Musurekar P (1989) Production of lovastatin, an inhibitor of cholesterol accumulation in humans. In: Demain AL, Somkuti GA, Hunter-Cevera JC, Rossmoore HW (eds) Novel Microbial Products for Medicine and Agriculture. Elsevier, Amsterdam, pp 161-169
19. DA Burr XB Chen JC Vederas 2007 Syntheses of conjugated pyrones for the enzymatic assay of lovastatin nonaketide synthase, an iterative polyketide synthase Org Lett 9 161 164 10.1021/ol062763i 1:CAS:528:DC%2BD28XhtlWlsLzL
20. JL Casas-López JA Sánchez-Pérez JM Fernández-Sevilla FG Acién-Fernández E Molina-Grima Y Chisti 2003 Production of lovastatin by Aspergillus terreus: effects of the C:N ratio and the principal nutrients on growth and metabolite production Enzyme Microb Technol 33 270 277 10.1016/S0141-0229(03)00130-3 (Pubitemid 37288915)
21. JL Casas-López JA Sánchez-Pérez JM Fernández-Sevilla FG Acién-Fernández E Molina-Grima Y Chisti 2004 Fermentation optimization for the production of lovastatin by Aspergillus terreus: use of response surface methodology J Chem Technol Biotechnol 79 1119 1126 10.1002/jctb.1100 (Pubitemid 39335395)
22. JL Casas-López JA Sánchez-Pérez JM Fernández-Sevilla EM Rodríguez-Porcel Y Chisti 2005 Pellet morphology, culture rheology and lovastatin production in cultures of Aspergillus terreus J Biotechnol 116 61 77 10.1016/j.jbiotec.2004.10.005 (Pubitemid 40126167)
23. Chakravarti R, Sahai1 V (2004) Compactin-a review. Appl Microbiol Biotechnol 64:618-624
24. JK Chan RN Moore TT Nalashima JC Vederas 1983 Biosynthesis of mevinolin. Spectral assignment by double-quantum coherence NMR after high carbon-13 incorporation J Am Chem Soc 105 3334 3336 10.1021/ja00348a062 1:CAS:528:DyaL3sXhvFCks70%3D
25. CH Chen HY Hu YC Cho WH Hsu 2006 Screening of compactin-resistant microorganisms capable of converting compactin to pravastatin Curr Microbiol 53 108 112 10.1007/s00284-005-0276-7 1:CAS:528:DC%2BD28XmvFeitrg%3D (Pubitemid 44165837)
26. RD Couch GM Gaucher 2004 Rational elimination of Aspergillus terreus sulochrin production J Biotechnol 108 171 177 10.1016/j.jbiotec.2003.10.021 1:CAS:528:DC%2BD2cXhtV2ltr8%3D (Pubitemid 38177538)
27. SR Cummings DC Bauer 2000 Do statins prevent both cardiovascular disease and fracture? JAMA 283 3255 3257 10.1001/jama.283.24.3255 1:STN:280: DC%2BD3czisFejuw%3D%3D
28. J Davignon LA Leiter 2005 Ongoing clinical trials of the pleiotropic effects of statins Vasc Health Risk Manag 1 29 40 10.2147/vhrm.1.1.29.58937 1:CAS:528:DC%2BD28Xhtlars7nE
29. J Dulak A Józkowicz 2005 Anti-angiogenic and anti-inflammatory effects of statins: relevance to anti-cancer therapy Curr Cancer Drug Targets 5 579 594 10.2174/156800905774932824 1:CAS:528:DC%2BD2MXhtlegsbfO
30. A Durand 2003 Bioreactor designs for solid state fermentation Biochem Eng J 13 113 125 10.1016/S1369-703X(02)00124-9 1:CAS:528:DC%2BD3sXmsFemtA%3D%3D (Pubitemid 36205527)
31. CJ Edwards TD Spector 2002 Statins as modulators of bone formation Arthritis Res 4 151 153 10.1186/ar399 1:CAS:528:DC%2BD38XjsVCksbw%3D (Pubitemid 34460752)
32. A Endo M Kuroda K Tanzawa 1976 Competitive inhibition of 3-hydroxy-3methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites having hypocholesterolemic activity FEBS Lett 72 323 326 10.1016/0014-5793(76)80996-9 1:CAS:528:DyaE2sXosFartw%3D%3D (Pubitemid 8017240)
33. A Endo Y Negishi T Iwashita K Mizukawa M Hirama 1985 Biosynthesis of ML-236B (compactin) and monacolin K J Antibiot (Tokyo) 38 444 448 1:CAS:528:DyaL2MXitVSrtbo%3D
34. Endo A, Terahara A, kitano N, Ogiso A, Mitsui S (1979) ML236B carboxylic acid derivatives and their use as antihyperlipidemic agents. U.S. Patent 4,137,322
35. M Farnier J Davignon 1998 Current and future treatment of hyperlipidemia: the role of statins Am J Cardiol 82 3J 10 10.1016/S0002-9149(98)00423-8 1:CAS:528:DyaK1cXmtFWrurg%3D (Pubitemid 28429253)
36. K Fassbender M Simons C Bergmann M Stroick D Lutjohann 2001 Simvastatin strongly reduces levels of Alzheimer's disease beta-amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo Proc Natl Acad Sci USA 98 5856 5861 10.1073/pnas.081620098 1:CAS:528:DC%2BD3MXjs1Wnt70%3D (Pubitemid 32435732)
37. CD Furberg 1999 Natural statins and stroke risk Circulation 99 185 188 1:STN:280:DyaK1M7htVOitA%3D%3D
38. M Galán F Taix F Carrascosa 2004 Estatinas: eficacia, seguridad e indicaciones Inf Ter Sist Nac Salud 28 89 100
39. Giovannozzi S, Tiso N (2007) Aspects of design of bioreactors in SSF. In: Pandey A, Larroche C, Soccol CR (eds) Current Developments in Solid-State Fermentation. Asiatech Publishers, Inc, New Delhi, pp 117-144
40. SA Glynn D O'Sullivan AJ Eustace M Clynes N O'Donovan 2008 The 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, simvastatin, lovastatin and mevastatin inhibit proliferation and invasion of melanoma cells BMC Cancer 8 9 10.1186/1471-2407-8-9 10.1186/1471-2407-8-9 (Pubitemid 351309029)
41. MD Greenspan JB Yudrovitz 1985 Mevinolinic acid biosynthesis by Aspergillus terreus and its relationship to fatty acid biosynthesis J Bacteriol 162 704 707 1:CAS:528:DyaL2MXitFyjtbY%3D
42. L Hendrickson CR Davis C Roach DK Nguyen T Aldrich PC McAda CD Reeves 1999 Lovastatin biosynthesis in Aspergillus terreus: characterization of blocked mutants, enzyme activities and multifunctional polyketide synthase gene Chem Biol 6 429 439 10.1016/S1074-5521(99)80061-1 1:CAS:528:DyaK1MXksFKrt78%3D (Pubitemid 29311480)
43. Herold S (2007) Prescriptions for Cholesterol Drugs Rise with New Generics. In: Consumers Reports. Best Buy Drugs. The Statins. Available on line. http://www.consumerreports.org/health/resources/pdf/best-buy-drugs/Statins. Accessed Feruary 13, 2007
44. CW Hesseltine 1977 Solid-state fermentation. Part 1 Proc Biochem 12 24 27 1:CAS:528:DyaE2sXlvF2jtL0%3D
45. CW Hesseltine 1977 Solid-state fermentation. Part 2 Proc Biochem 12 29 32 1:CAS:528:DyaE1cXoslKktA%3D%3D
46. K Höglund O Wiklund H Vanderstichele, et al. 2004 Plasma levels of β-amyloid (1-40), β-amyloid (1-42), and total β- amyloid remain unaffected in adult patients with hypercholesterolemia after treatment with statins Arch Neurol 61 333 337 10.1001/archneur.61.3.333 (Pubitemid 38327348)
47. U Hölke M Höfer J Lenz 2004 Biotechnological advantages of laboratory-scale solid-state fermentation with fungi Appl Microbiol Biotechnol 64 175 186 10.1007/s00253-003-1504-3 Hesseltine 1977a; 1977b (Pubitemid 38559067)
48. U Hölker J Lenz 2005 Solid-state fermentation-are there any biotechnological advantages? Current Opinion in Microbiology 8 301 306 10.1016/j.mib.2005.04.006 (Pubitemid 40813072)
49. M Hosobuchi T Shiori J Ohyama M Arai S Iwado H Yoshikawa 1993 Production of ML-236B, and inhibitor of 3-hydroxy-3-methylglutaryl CoA reductase, by Penicillium citrinum: improvement of strain and culture conditions Biosci Biotechnol Biochem 57 1414 1419 10.1271/bbb.57.1414 1:CAS:528: DyaK2cXnsFGitw%3D%3D
50. M Hosobuchi K Kurosawa H Yoshikawa 1993 Application of computer to monitoring and control of fermentation process: microbial conversion of ML-236B to pravastatin J Ferment Bioeng 76 482 486 10.1016/0922-338X(93)90245-4 1:CAS:528:DyaK2cXhtVGjt7k%3D (Pubitemid 24038695)
51. M Hosobuchi K Ogawa H Yoshikawa 1993 Morphology study in production of ML-236B, a precursor of pravastatin sodium by Penicillium citrinum J Ferment Bioeng 76 470 475 10.1016/0922-338X(93)90243-2 1:CAS:528:DyaK2cXhtVGjt7s%3D (Pubitemid 24038693)
52. X Huang H Chen WC Miller, et al. 2007 Lower low-density lipoprotein cholesterol levels are associated with Parkinsońs disease Mov Disord 22 377 81 10.1002/mds.21290 (Pubitemid 46569693)
53. CR Hutchinson J Kennedy C Park G Kendrew K Auclair JC Vederas 2000 Aspects of the biosynthesis of non-aromatic fungal polyketides by iterative polyketide synthases Antonie van Leeuwenhoek 78 287 295 10.1023/A:1010294330190 1:CAS:528:DC%2BD3MXktVOhu78%3D (Pubitemid 32401250)
54. SS Jick H Choi L Li IB McInnes N Sattar 2009 Hyperlipidaemia, statin use and the risk of developing rheumatoid arthritis Ann Rheum Dis 68 546 551 10.1136/ard.2008.091967 1:CAS:528:DC%2BD1MXkt1emt70%3D
55. WB Kannel TR Dawber A Kaban SJL Revotskie 1961 Factors of risk in the development of coronary heart disease -six year follow up experience; the Farmingham Study Ann Intern Med 40 602 609
56. NP Keller TM Hohn 1997 Metabolic pathway gene clusters in filamentous fungi Fungal Genet Biol 21 17 29 10.1006/fgbi.1997.0970 1:CAS:528: DyaK2sXitlKlsL0%3D (Pubitemid 27226551)
57. J Kennedy K Auclair G Kendrew P Cheonseok JC Vederas CR Hutchinson 1999 Modulation of polyketide synthase activity by accessory proteins during lovastatin biosynthesis Science 284 1368 1372 10.1126/science.284.5418.1368 1:CAS:528:DyaK1MXjs1WhtLg%3D (Pubitemid 29289665)
58. J Kidd 2006 Life after statin patent expiries Nature Revs/Drug Discovery 5 813 814 10.1038/nrd2156 1:CAS:528:DC%2BD28XhtVajsbbO (Pubitemid 44480534)
59. K Kimura D Komagata S Murakawa A Endo 1990 Biosynthesis of monacolins: conversion of monacolin J to monacolin K (mevilonil) J Antibiot (Tokyo) 43 1621 1622 1:CAS:528:DyaK3MXnvVCitQ%3D%3D
60. PH Kodaman AJ Duleba 2008 Statins in the treatment of polycystic ovary syndrome Semin Reprod Med 26 1 127 38 10.1055/s-2007-992933 1:CAS:528: DC%2BD1cXitFShu7o%3D
61. D Komagata H Shimada S Murakawa A Endo 1989 Biosynthesis of monacolins: conversion of monacolin L to monacolin J by a monooxygenase of Monascus ruber J Antibiot (Tokyo) 42 407 412 1:CAS:528:DyaL1MXktlGiu78%3D
62. MS Kumar SK Jana V Senthil V Shashanka SV Kumar Sadhukhan 2000 Repeated fed-batch process for improving lovastatin production Process Biochem 36 363 368 10.1016/S0032-9592(00)00222-3 1:CAS:528:DC%2BD3cXnvF2nsLs%3D (Pubitemid 30818288)
63. LST Lai CC Pan BK Tzeng 2003 The influence of medium design on lovastatin production and pellet formation with a high producing mutant of Aspergillus terreus in submerged cultures Process Biochem 38 1317 1326 10.1016/S0032- 9592(02)00330-8 1:CAS:528:DC%2BD3sXkt1aqs78%3D (Pubitemid 36708615)
64. BP Leung N Sattar A Crilly, et al. 2003 A Novel Anti-inflammatory role for simvastatin in inflammatory arthritis J Immunol 170 1524 1530 1:CAS:528:DC%2BD3sXnvVOqsg%3D%3D
65. YL Lin TH Wang MH Lee NW Su 2008 Biologically active components and nutraceuticals in the Monascus-fermented rice: a review Appl Microbiol Biotechnol 77 965 973 10.1007/s00253-007-1256-6 1:CAS:528:DC%2BD2sXhsVaisrnI (Pubitemid 50005214)
66. SM Ma Y Tang 2007 Biochemical characterization of the minimal polyketide synthase domains in the lovastatin nonaketide synthase LovB FEBS Journal 274 2854 28 10.1111/j.1742-4658.2007.05818.x 1:CAS:528:DC%2BD2sXmvVWrtbg%3D (Pubitemid 46800552)
67. M Manzoni M Rollini 2002 Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol-lowering drugs Appl Microbiol Biotechnol 58 555 564 10.1007/s00253-002-0932-9 1:CAS:528:DC%2BD38Xjs12ktL0%3D (Pubitemid 34299219)
68. M Manzoni M Rollini S Bergomi V Cavazzoni 1998 Production and purification of statins from Aspergillus terreus strains Biotechnol Techniques 12 529 532 10.1023/A:1008851430560 1:CAS:528:DyaK1cXltl2nurw%3D (Pubitemid 28358524)
69. DJ Maron S Fazio MF Linton 2000 Current perspective on statins Circulation 101 207 213 1:CAS:528:DC%2BD3cXptFKlug%3D%3D
70. H Masahiko K Ogawa H Yoshikawa 1993 Application of computer to monitoring and control of fermentation process: microbiological conversion of ML-236B Na to pravastatin Biotechnol Bioeng 42 815 820 10.1002/bit.260420705
71. Metkinen (2009) Available on line. http://www.metkinen.fi/. Accessed September 1, 2009
72. Mistry K (2007) Statins have once again hit the news. Yale Scientific Magazine 81.2.
73. Monaghan R, Alberts L, Hoffman AW, Carl H, Albers-Schonberg G (1981) Hypocholesteremic fermentation products and process of preparation. US Patent 4294926
74. ZA Massy C Guijarro 2001 Statins: effects beyond cholesterol lowering Nephrol Dial Transplant 16 1738 1741 10.1093/ndt/16.9.1738 1:CAS:528: DC%2BD3MXns1yrt7o%3D
75. DW McCarey N Sattar IB McInnes 2005 Do the pleiotropic effects of statins in the vasculature predict a role in inflammatory diseases? Arthritis Res Ther 7 55 61 10.1186/ar1496 1:CAS:528:DC%2BD2MXhslahtbg%3D (Pubitemid 40439439)
76. RN Moore G Bigam JK Chan AM Hogg TT Nakashima JC Vederas 1985 Biosynthesis of the hypocholesterolemic agent mevinolin by by Aspergillus terreus. Determination of the origin of carbon, hydrogen, and oxygen atoms by 13C NMR and mass spectrometry J Am Chem Soc 107 3694 3701 10.1021/ja00298a046 1:CAS:528:DyaL2MXktF2mtLw%3D (Pubitemid 15237517)
77. Y Moride RA Hegele A Langer R McPherson DB Miller S Rinfret 2008 Clinical and public health assessment of benefits and risks of statins in primary prevention of coronary events: Resolved and unresolved issues Can J Cardiol 24 293 300
78. G Mundy R Garrett S Harris, et al. 1999 Stimulation of bone formation in vitro and in rodents by statins Science 286 1946 1949 10.1126/science.286.5446. 1946 1:CAS:528:DyaK1MXnvFSiu78%3D
79. DT Nash 2005 Relationship of C-reactive protein, metabolic syndrome and diabetes mellitus: potential role of statins J Natl Med Assoc 97 1600 1607
80. S Negishi ZC Huang K Hasumi S Murakawa A Endo 1986 Productivity of monacolin K (mevinolin) in the genus Monascus J Fement Eng 64 509 511 1:CAS:528:DyaL2sXks12msA%3D%3D
81. O Neuhaus HP Hartung 2007 Evaluation of atorvastatin and simvastatin for treatment of multiple sclerosis Expert Rev Neurother 7 547 56 10.1586/14737175.7.5.547 1:CAS:528:DC%2BD2sXmslKqtbk%3D (Pubitemid 46743446)
82. N Novak S Gerdin M Berovic 1997 Increased lovastatin formation by Aspergillus terreus using repeated fed-batch process Biotechnol Lett 19 947 948 10.1023/A:1018322628333 1:CAS:528:DyaK2sXntVGqsbY%3D (Pubitemid 27466434)
83. LP Ooijkaas FJ Weber RM Buitelaar J Tramper A Rinzema 2000 Defined media and inert supports: their potential as solid-state fermentation production systems Trends Biotechnol 18 356 360 10.1016/S0167-7799(00)01466-9 1:CAS:528:DC%2BD3cXltVOgsbk%3D (Pubitemid 30456350)
84. K Pahan 2006 Lipid-lowering drugs Cell Mol Life Sci 63 1165 1178 10.1007/s00018-005-5406-7 1:CAS:528:DC%2BD28XlvVeqt7g%3D (Pubitemid 43939003)
85. K Pahan FG Sheikh AM Namboodiri I Singh 1997 Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary ostrocytes, microglia, and macrophages J Clin Invest 100 2671 9 10.1172/JCI119812 1:CAS:528:DyaK2sXotVakt7g%3D
86. Pandey A, Larroche C, Soccol C (2007) General considerations about solid-state fermentation processes. In: Pandey A, Larroche C, Soccol CR (eds) Current Developments in Solid-State Fermentation. New Delhi, Asiatech Publishers Inc, pp 13-25
87. JW Park JK Lee TJ Kwon DH Yi YJ Kim SH Moon HH Suh SM Kang YI Park 2003 Bioconversion of compactin into pravastatin by Streptomyces sp Biotechnol Lett 25 1827 1831 10.1023/A:1026281914301 1:CAS:528:DC%2BD3sXotlajsL8%3D (Pubitemid 37436046)
88. S Pedrini TL Carter G Prendergast, et al. 2005 Modulation of statin-activated shedding of Alzheimer APP ectodomain by ROCK PLos Med 2 1 e81 10.1371/journal.pmed.0020018 10.1371/journal.pmed.0020018 (Pubitemid 40412736)
89. T Robinson D Singh P Nigam 2001 Solid-state fermentation a promising microbial technology for secondary metabolite production Appl Microbiol Biotechnol 55 284 289 10.1007/s002530000565 1:CAS:528:DC%2BD3MXjtF2itbw%3D (Pubitemid 32295780)
90. EM Rodríguez-Porcel JL Casas-López JA Sánchez- Pérez JM Fernández-Sevills Y Chisti 2005 Effects of pellet morphology on broth rheology in fermentations of Aspergillus terreus Biochem Eng J 26 139 144 10.1016/j.bej.2005.04.011 (Pubitemid 41355054)
91. EM Rodríguez-Porcel JL Casas-López JA Sánchez- Pérez Y Chisti 2007 Enhanced production of lovastatin in a bubble column by Aspergillus terreus using two-stage feeding strategy J Chem Technol Biotechnol 82 58 64 10.1002/jctb.1636 (Pubitemid 46138688)
92. A Seenivasan S Subhagar R Aravindan T Viruthagiri 2008 Microbial production and biomedical applications of lovastatin Indian J Pharm Sci 70 701 709 10.4103/0250-474X.49087
93. Serizawa N, Nakagawa K, Hamano K, Tsujita Y, Terahara A, Kuwano H (1983) Microbial hydroxylation of ML-236B (compactin) and monacolin K (MB-530 B). J Antibiot 36:604-607
94. Serizawa N, Watanabe I (1997) Actinomycete promoter. European Patent EP0776974 (A2)
95. S Shaligram KS Sudheer SS Rekha G Szakacs A Pandey 2008 Compactin production in solid-state fermentation using orthogonal array method by P. brevicompactum Biochem Eng J 41 295 300 10.1016/j.bej.2008.05.011 1:CAS:528:DC%2BD1cXhtVSgtL7P
96. M Shiao H Don 1987 Biosynthesis of mevinolin, a hypocholesterolemic fungal metabolite, in Aspergillus terreus Proc Nat Sci Counc 11 223 231 1:CAS:528:DyaL1cXhtV2gsLc%3D
97. J Staunton KJ Weissman 2001 Polyketide biosynthesis: a millennium review Nat Prod Rep 18 380 416 10.1039/a909079g 1:CAS:528:DC%2BD3MXltlyqsbo%3D (Pubitemid 32773840)
98. S Suryanarayan 2003 Current industrial practice in solid state fermentations for secondary metabolite production: the Biocon India experience Biochem Eng J 13 189 195 10.1016/S1369-703X(02)00131-6 1:CAS:528: DC%2BD3sXmsFeltg%3D%3D (Pubitemid 36205533)
99. C Turesson LTH Jacobsson EL Matteson 2008 Cardiovascular co-morbidity in rheumatic diseases Vasc Heal Risk Manag 4 605 614
100. Van den Berg MA, Hans M, Streekstra H (2007) Metod for the production of simvastatin. International Patent WO 2007147801 A1
101. VA Vinci TD Hoerner AD Coffman TG Schimmel RL Dabora AC Kirpekar CL Ruby RW Stieber 1999 Mutants of a lovastatin-hyperproducing Aspergillus terreus deficient in the production of sulochrin J Ind Micro 8 113 120 10.1007/BF01578762
102. CY Wang PY Liu JK Liao 2008 Pleiotropic effects of statin therapy: molecular mechanisms and clinical results Trends Mol Med 14 37 44 10.1016/j.molmed.2007.11.004 1:CAS:528:DC%2BD1cXptlehsg%3D%3D
103. B Wolozin 2002 Cholesterol and Alzheimeŕs disease Biochem Soc Trans 30 525 529 10.1042/BST0300525 1:CAS:528:DC%2BD38XntVent7o%3D (Pubitemid 35001591)
104. X Xie K Watanabe WA Wojcicki CC Wand Y Tang 2006 Biosynthesis of lovastatin analogs with a broad specificity acyltransferase Chem Biol 13 1161 1169 10.1016/j.chembiol.2006.09.008 1:CAS:528:DC%2BD28Xht1Cis7bJ (Pubitemid 44762191)
105. X Xie Y Tang 2007 Efficient synthesis of simvastatin using whole-cell biocatalysis Appl Environ Microbiol 73 2054 2060 10.1128/AEM.02820-06 1:CAS:528:DC%2BD2sXkt1Kqtrg%3D (Pubitemid 46649493)
106. X Xie W Wong Y Tang 2007 Improving simvastatin bioconversion in Escherichia coli by deletion of bioH Metabol Eng 9 379 386 10.1016/j.ymben.2007. 05.006 1:CAS:528:DC%2BD2sXotlSks7Y%3D
107. X Xie I Pashkov X Gao JL Guerrero TO Yeates Y Tang 2009 Rational improvement of simvastatin synthase solubility in Escherichia coli leads to higher whole-cell biocatalyctic activity Biotechnol Bioeng 102 20 28 10.1002/bit.22028 1:CAS:528:DC%2BD1MXit12r
108. X Xie MJ Meehan W Xu PC Dorrestein Y Tang 2009 Acyltransferase-mediated polyketide release from a fungal megasynthase J Am Chem Soc 131 8388 8389 10.1021/ja903203g 1:CAS:528:DC%2BD1MXmsFWmt7c%3D
109. Ykema A, Streekstra H, Luiten RGM (1999) Statin production by fermentation. International Patent WO/1999/010499